- Patent Title: (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
-
Application No.: US15536496Application Date: 2015-12-14
-
Publication No.: US10577348B2Publication Date: 2020-03-03
- Inventor: Pranav Gupta , Jason Wan , Scott T. Trzaska
- Applicant: Merck Sharp & Dohme Corp. , Pranav Gupta , Jason Wan , Scott T. Trzaska
- Applicant Address: US NJ Rahway
- Assignee: MERCK SHARP & DOHME CORP.
- Current Assignee: MERCK SHARP & DOHME CORP.
- Current Assignee Address: US NJ Rahway
- Agent Jeffrey P. Bergman; Catherine D. Fitch
- International Application: PCT/US2015/065428 WO 20151214
- International Announcement: WO2016/100147 WO 20160623
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K9/48 ; A61K31/444
Abstract:
A composition comprising (S)—N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide and hypromellose acetate succinate for pharmaceutical preparations, especially capsule preparations.
Public/Granted literature
Information query
